Non-Chemotherapy Combo Approved for Treatment-Naïve CLL/SLL Patients

The US Food and Drug Administration FDA has approved IMBRUVICA ibrutinib in combination with Gazyva obinutuzumab for treatments of patients with chronic lymphocytic leukemiasmall lymphocytic lymphoma CLLSLL 1 The FDA approval was based on results from the [...]